Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $1.17 $1.66 Friday, 10th May 2024 IFRX stock ended at $1.18. This is 1.67% less than the trading day before Thursday, 9th May 2024. During the day the stock fluctuated 6.41% from a day low at $1.17 to a day high of $1.25.
90 days $1.17 $1.92
52 weeks $1.14 $5.20

Historical InflaRx N.V. prices

Date Open High Low Close Volume
Feb 29, 2024 $1.71 $1.92 $1.71 $1.78 263 193
Feb 28, 2024 $1.63 $1.76 $1.59 $1.74 375 826
Feb 27, 2024 $1.48 $1.73 $1.48 $1.65 1 003 170
Feb 26, 2024 $1.53 $1.55 $1.49 $1.50 236 548
Feb 23, 2024 $1.47 $1.54 $1.40 $1.51 456 366
Feb 22, 2024 $1.55 $1.55 $1.46 $1.47 227 452
Feb 21, 2024 $1.55 $1.55 $1.49 $1.51 93 527
Feb 20, 2024 $1.53 $1.57 $1.50 $1.53 111 620
Feb 16, 2024 $1.56 $1.58 $1.51 $1.55 465 055
Feb 15, 2024 $1.49 $1.60 $1.49 $1.54 174 463
Feb 14, 2024 $1.60 $1.62 $1.47 $1.47 631 239
Feb 13, 2024 $1.59 $1.70 $1.56 $1.58 278 883
Feb 12, 2024 $1.54 $1.72 $1.54 $1.65 841 898
Feb 09, 2024 $1.62 $1.65 $1.52 $1.52 126 677
Feb 08, 2024 $1.60 $1.70 $1.57 $1.58 201 103
Feb 07, 2024 $1.70 $1.70 $1.57 $1.57 74 169
Feb 06, 2024 $1.57 $1.65 $1.57 $1.64 56 136
Feb 05, 2024 $1.62 $1.63 $1.57 $1.59 41 555
Feb 02, 2024 $1.70 $1.72 $1.62 $1.62 49 378
Feb 01, 2024 $1.65 $1.75 $1.63 $1.70 90 533
Jan 31, 2024 $1.65 $1.71 $1.61 $1.62 36 837
Jan 30, 2024 $1.74 $1.74 $1.65 $1.65 49 024
Jan 29, 2024 $1.56 $1.73 $1.56 $1.72 117 315
Jan 26, 2024 $1.53 $1.62 $1.47 $1.54 128 881
Jan 25, 2024 $1.68 $1.68 $1.50 $1.50 194 600
Click to get the best stock tips daily for free!

About InflaRx N.V.

InflaRx N.V. InflaRx N.V., a clinical-stage biopharmaceutical company, discovers and develops inhibitors using C5a technology primarily in Germany and the United States. The company's C5a is an inflammatory mediator that is involved in the progression of a variety of autoimmune and other inflammatory diseases. Its lead product candidate is vilobelimab, a novel intravenously delivered first-in-class anti-C5a monoclonal antibody, which completed the Phase III c... IFRX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT